Ketan K Badani, MD

Dr. Ketan K. Badani is Professor of Urology, Icahn School of Medicine at Mount Sinai, Vice Chairman of Urology and Robotic Operations at Mount Sinai Health System, Director of Robotic Surgery at Mount Sinai West, and the Director of the Comprehensive Kidney Cancer Program At Mount Sinai Health System.

Dr. Badani is recognized as a world leader in the research and treatment of urologic oncology.  Specifically, he has focused his work on prostate and kidney cancer.  Dr. Badani has led teams that first developed and published techniques for minimally invasive robotic kidney cancer surgery.  His technique of robotic partial nephrectomy, The “F.A.S.T.” procedure has been published and taught around the world to treat patients with renal tumors.  Dr. Badani leads a team seeking to improve treatment of these cancers by finding less invasive and effective therapy, while maintaining quality of life factors after surgery. 

Dr. Badani has performed nearly 4,000 robotic procedures in his career, placing him in the top 1% of urologists worldwide. He is one the preeminent practitioners in the world for robotic partial nephrectomy for complex kidney tumors, and robotic prostatectomy for localized prostate cancer; he has the largest combined experience in robotic kidney and prostate cancer in the New York area.  Dr. Badani’s clinical expertise spans both surgical and non-surgical approaches to treatment of urologic cancers.  He has just completed one of the largest decision impact studies evaluating genomic biomarkers for active surveillance in men with low risk prostate cancer.

As Visiting Professor, Dr. Badani has given lectures and demonstrated surgery in over 20 countries.  Most recently he visited prominent institutions in the United States, Canada, Brazil, Japan, India, Malaysia, Venezuela, China, Spain, and Turkey to teach his technique.  He is the author of over 150 peer-reviewed publications and has presented over 200 abstracts at national and international meetings.  He has led the prostate and kidney cancer research program at Columbia University Medical Center for the past 7 years.  Dr. Badani is involved in numerous clinical trials, feasibility and safety studies of new technology, and health related quality of life outcomes research.   He serves as an editor and/or reviewer for numerous publications including Cancer, Journal of Urology, Urologic Oncology, Journal of Endourology, among others.

As Director of the Comprehensive Kidney Cancer Program at Mount Sinai Heath System, Dr. Badani will develop a multispecialty clinical program for kidney cancer patients that will span the treatment spectrum including surgery, nephrology, interventional radiology, and complementary medicine.  Clinically, the program will allow individualized care to each patient with kidney cancer based on the tumor stage, grade, and overall health.  Academically, the program will be on the cutting edge for innovative technology based research, and latest clinical trials.

Dr. Badani graduated in the top of his class from Case Western Reserve University School of Medicine in Cleveland, Ohio.  He went on to complete his urology residency at the world renowned Vattikuti Urology Institute at Henry Ford Hospital in Detroit, MI (his hometown).  He also completed a fellowship in minimally invasive urologic oncology at the Vattikuti Urology Institute, where robotic urologic surgery was first performed in the United States.  Upon completion of his training, Dr. Badani joined the faculty at Columbia University Medical Center.

Dr. Badani will see patients at two locations: Mount Sinai Hospital (5 East 98th Street) and Mount Sinai West (425 West 59th Street).  His office can be contacted by calling (212)241-3919.  He can be reached via email at ketan.badani@mountsinai.org.

Dr. Badani Patient Stories:  

https://www.mountsinai.org/about/patient-stories/robotic-partial-nephrectomy-treats-kidney-tumor